MoneyWorks4Me

Sigachi Industries - Quaterly Results

27 May 2024 Evaluate
The March 2024 quarter revenue stood at Rs. 836.55 millions, up 9.96% as compared to Rs. 760.80 millions during the corresponding quarter last year.A slim rise of 24.40% was recorded in the Net profit for the quarter ended March 2024 to Rs. 117.30  millions  From Rs. 94.29 millions.Operating Profit saw a handsome growth to 221.38 millions from 155.53 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 836.55 760.80 9.96 3175.00 2903.24 9.36 3175.00 2903.24 9.36
Other Income 71.66 15.50 362.32 115.73 66.72 73.46 115.73 66.72 73.46
PBIDT 221.38 155.53 42.34 708.66 624.85 13.41 708.66 624.85 13.41
Interest 24.25 14.12 71.74 70.20 42.87 63.75 70.20 42.87 63.75
PBDT 197.13 141.41 39.40 638.46 581.98 9.70 638.46 581.98 9.70
Depreciation 27.23 19.75 37.87 87.09 66.21 31.54 87.09 66.21 31.54
PBT 169.90 121.66 39.65 551.37 515.77 6.90 551.37 515.77 6.90
TAX 52.60 27.37 92.18 141.23 100.18 40.98 141.23 100.18 40.98
Deferred Tax 16.60 6.06 173.93 32.08 -2.06 -1657.28 32.08 -2.06 -1657.28
PAT 117.30 94.29 24.40 410.14 415.59 -1.31 410.14 415.59 -1.31
Equity 328.20 307.43 6.76 328.20 307.43 6.76 328.20 307.43 6.76
PBIDTM(%) 26.46 20.44 29.45 22.32 21.52 3.71 22.32 21.52 3.71
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..